Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

被引：10

作者：

Elshaer, Amani ^{[1
]}

Chascsa, David M. H. ^{[2
,3
]}

Lizaola-Mayo, Blanca C. ^{[2
,3
]}

机构：

[1] Mayo Clin, Dept Internal Med, Scottsdale, AZ 85054 USA

[2] Mayo Clin, Div Gastroenterol & Hepatol, Scottsdale, AZ 85054 USA

[3] Mayo Clin, Transplant Ctr, Dept Med, Scottsdale, AZ 85054 USA

来源：

LIFE-BASEL | 2024年 / 14卷 / 07期

关键词：

metabolic-associated steatotic liver disease; fibrosis; cirrhosis; obesity; weight loss; lifestyle modification; pharmacotherapy; bariatric surgery; LIFE-STYLE MODIFICATION; CLINICAL-PRACTICE UPDATE; GLUCAGON-LIKE PEPTIDE-1; CORONARY-HEART-DISEASE; FATTY LIVER; BARIATRIC SURGERY; INSULIN-RESISTANCE; WEIGHT-LOSS; NONALCOHOLIC STEATOHEPATITIS; AMERICAN ASSOCIATION;

D O I：

10.3390/life14070844

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a liver disorder characterized by steatosis with underlying metabolic risk factors. The prevalence of MASLD continues to rise, leading to increased patient risk of various complications. Recent research has been focused on new therapeutic strategies to reduce the incidence of MASLD and provide effective treatment plans to prevent further irreversible liver damage. The treatment approach is multifactorial, with a primary focus on weight loss and management of underlying comorbidities through lifestyle modifications, pharmacotherapy, or surgical options. Ongoing research is exploring new pharmacological therapies that could enhance the treatment of MASLD.

引用

页数：21

共 113 条

[81] Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic [J].

Rao, Guocheng ;

Peng, Xi ;

Li, Xinqiong ;

An, Kang ;

He, He ;

Fu, Xianghui ;

Li, Shuangqing ;

An, Zhenmei .

FRONTIERS IN MEDICINE, 2023, 10

[82] AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease [J].

Rinella, Mary E. ;

Neuschwander-Tetri, Brent A. ;

Siddiqui, Mohammad Shadab ;

Abdelmalek, Manal F. ;

Caldwell, Stephen ;

Barb, Diana ;

Kleiner, David E. ;

Loomba, Rohit .

HEPATOLOGY, 2023, 77 (05) :1797-1835

[83] ACETYLATION OF PROSTAGLANDIN SYNTHASE BY ASPIRIN [J].

ROTH, GJ ;

STANFORD, N ;

MAJERUS, PW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) :3073-3076

[84] The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease [J].

Ryan, Marno C. ;

Itsiopoulos, Catherine ;

Thodis, Tania ;

Ward, Glenn ;

Trost, Nicholas ;

Hofferberth, Sophie ;

O'Dea, Kerin ;

Desmond, Paul V. ;

Johnson, Nathan A. ;

Wilson, Andrew M. .

JOURNAL OF HEPATOLOGY, 2013, 59 (01) :138-143

[85] Impact of coffee on liver diseases: a systematic review [J].

Saab, Sammy ;

Mallam, Divya ;

Cox, Gerald A. ;

Tong, Myron J. .

LIVER INTERNATIONAL, 2014, 34 (04) :495-504

[86] Molecular Bases Underlying the Hepatoprotective Effects of Coffee [J].

Salomone, Federico ;

Galvano, Fabio ;

Li Volti, Giovanni .

NUTRIENTS, 2017, 9 (01)

[87] The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux [J].

Samuel, Varman T. ;

Shulman, Gerald I. .

JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (01) :12-22

[88] Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. [J].

Sanyal, Arun J. ;

Chalasani, Naga ;

Kowdley, Kris V. ;

McCullough, Arthur ;

Diehl, Anna Mae ;

Bass, Nathan M. ;

Neuschwander-Tetri, Brent A. ;

Lavine, Joel E. ;

Tonascia, James ;

Unalp, Aynur ;

Van Natta, Mark ;

Clark, Jeanne ;

Brunt, Elizabeth M. ;

Kleiner, David E. ;

Hoofnagle, Jay H. ;

Robuck, Patricia R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18) :1675-1685

[89] Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content [J].

Sasaki, Yusuke ;

Asahiyama, Masato ;

Tanaka, Toshiya ;

Yamamoto, Shogo ;

Murakami, Kentaro ;

Kamiya, Wakana ;

Matsumura, Yoshihiro ;

Osawa, Tsuyoshi ;

Anai, Motonobu ;

Fruchart, Jean-Charles ;

Aburatani, Hiroyuki ;

Sakai, Juro ;

Kodama, Tatsuhiko .

SCIENTIFIC REPORTS, 2020, 10 (01)

[90] Mechanisms of insulin resistance in humans and possible links with inflammation [J].

Savage, DB ;

Petersen, KF ;

Shulman, GI .

HYPERTENSION, 2005, 45 (05) :828-833

← 3 4 5 6 7 8 9 10 11 12 →